Physician profile
Robert William Ward
NPI 1558337501
$1,871.13
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $842 · 2020: $571 · 2021: $441 · 2022: $16.48.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $322.51 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $210.25 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $208.88 | 2019-2021 | |
| Electromed, INC. | $182.16 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $170.61 | 2019-2021 | |
| Philips North America LLC | $157.31 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $108.53 | 2019-2020 | |
| Vero Biotech INC. | $84.43 | 2020 | |
| Jazz Pharmaceuticals INC. | $66.87 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $61.73 | 2019-2020 | |
| Mylan Specialty L.P. | $58.10 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $39.26 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $26.26 | 2019 | |
| Inogen, INC. | $24.96 | 2021 | |
| Novartis Pharmaceuticals Corporation | $24.77 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Resmed Corp | $20.61 | 2020 | |
| Genzyme Corporation | $19.36 | 2020 | |
| Paratek Pharmaceuticals, INC. | $16.92 | 2021 | |
| Harmony Biosciences LLC | $14.52 | 2020 | |
| Pulmonx Corporation | $13.96 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.29 | 2020 | |
| Grifols USA, LLC | $13.25 | 2019 | |
| Advanced Respiratory, INC | $12.59 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.